$HZNP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Horizon Therapeutics Public Ltd Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Horizon Therapeutics Public Ltd Co. Get notifications about new insider transactions in Horizon Therapeutics Public Ltd Co for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 12 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 27 2018 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 31,000 | 0 | 31,000 | |
Mar 27 2018 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 13.86 | 13,733 | 190,339 | 92,262 | 106 K to 92.3 K (-12.96 %) |
Mar 27 2018 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 31,000 | 0 | 105,995 | 75 K to 106 K (+41.34 %) |
Mar 27 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 31,000 | |
Mar 27 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 13.86 | 9,083 | 125,890 | 39,106 | 48.2 K to 39.1 K (-18.85 %) |
Mar 27 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 48,189 | 17.2 K to 48.2 K (+180.35 %) |
Mar 27 2018 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 125,000 | 0 | 125,000 | |
Mar 27 2018 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 13.86 | 55,375 | 767,498 | 543,700 | 599.1 K to 543.7 K (-9.24 %) |
Mar 27 2018 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 125,000 | 0 | 599,075 | 474.1 K to 599.1 K (+26.37 %) |
Mar 07 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,025 | 0 | 0 | |
Mar 07 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 15.83 | 13,836 | 219,024 | 17,189 | 31 K to 17.2 K (-44.60 %) |
Mar 07 2018 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,025 | 0 | 31,025 | 0 to 31 K |
Feb 22 2018 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Option Exercise | M | 0.00 | 2,181 | 0 | 6,545 | |
Feb 22 2018 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Payment of Exercise | F | 14.09 | 891 | 12,554 | 5,378 | 6.3 K to 5.4 K (-14.21 %) |
Feb 22 2018 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Buy | M | 0.00 | 2,181 | 0 | 6,269 | 4.1 K to 6.3 K (+53.35 %) |
Jan 18 2018 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | A | 0.00 | 20,100 | 0 | 20,100 | |
Jan 05 2018 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Option Exercise | M | 0.00 | 5,860 | 0 | 17,583 | |
Jan 05 2018 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Payment of Exercise | F | 14.44 | 3,058 | 44,158 | 4,088 | 7.1 K to 4.1 K (-42.79 %) |
Jan 05 2018 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Buy | M | 0.00 | 5,860 | 0 | 7,146 | 1.3 K to 7.1 K (+455.68 %) |
Jan 05 2018 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Option Exercise | A | 0.00 | 71,567 | 0 | 71,567 | |
Jan 05 2018 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Option Exercise | A | 15.37 | 146,685 | 2,254,548 | 146,685 | |
Dec 04 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 8,450 | 0 | 8,450 | |
Dec 04 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 14.33 | 2,730 | 39,121 | 36,647 | 39.4 K to 36.6 K (-6.93 %) |
Dec 04 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 8,450 | 0 | 39,377 | 30.9 K to 39.4 K (+27.32 %) |
Nov 02 2017 | HZNP | Horizon Pharma plc | Mosbrooker Eric | SVP, Orphan Busines ... | Option Exercise | M | 0.00 | 4,435 | 0 | 13,306 | |
Nov 02 2017 | HZNP | Horizon Pharma plc | Mosbrooker Eric | SVP, Orphan Busines ... | Payment of Exercise | F | 13.83 | 2,315 | 32,016 | 3,585 | 5.9 K to 3.6 K (-39.24 %) |
Nov 02 2017 | HZNP | Horizon Pharma plc | Mosbrooker Eric | SVP, Orphan Busines ... | Buy | M | 0.00 | 4,435 | 0 | 5,900 | 1.5 K to 5.9 K (+302.73 %) |
Oct 26 2017 | HZNP | Horizon Pharma plc | Happel David | EVP, Commercial Dev ... | Option Exercise | M | 0.00 | 7,953 | 0 | 23,860 | |
Oct 26 2017 | HZNP | Horizon Pharma plc | Happel David | EVP, Commercial Dev ... | Payment of Exercise | F | 13.53 | 4,150 | 56,150 | 5,089 | 9.2 K to 5.1 K (-44.92 %) |
Oct 26 2017 | HZNP | Horizon Pharma plc | Happel David | EVP, Commercial Dev ... | Buy | M | 0.00 | 7,953 | 0 | 9,239 | 1.3 K to 9.2 K (+618.43 %) |
Sep 20 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | M | 0.00 | 7,874 | 0 | 0 | |
Sep 20 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Payment of Exercise | F | 12.10 | 2,381 | 28,810 | 29,881 | 32.3 K to 29.9 K (-7.38 %) |
Sep 20 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Buy | M | 0.00 | 7,874 | 0 | 32,262 | 24.4 K to 32.3 K (+32.29 %) |
Sep 13 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | M | 0.00 | 3,925 | 0 | 3,925 | |
Sep 13 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 13.42 | 1,841 | 24,706 | 66,110 | 68 K to 66.1 K (-2.71 %) |
Sep 13 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Buy | M | 0.00 | 3,925 | 0 | 67,951 | 64 K to 68 K (+6.13 %) |
Sep 13 2017 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Option Exercise | A | 0.00 | 64,056 | 0 | 64,056 | |
Sep 13 2017 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Option Exercise | A | 14.05 | 131,606 | 1,849,064 | 131,606 | |
Aug 07 2017 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | EVP, Primary Care B ... | Option Exercise | M | 0.00 | 18,750 | 0 | 37,500 | |
Aug 07 2017 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | EVP, Primary Care B ... | Payment of Exercise | F | 12.70 | 7,866 | 99,898 | 36,751 | 44.6 K to 36.8 K (-17.63 %) |
Aug 07 2017 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | EVP, Primary Care B ... | Buy | M | 0.00 | 18,750 | 0 | 44,617 | 25.9 K to 44.6 K (+72.49 %) |
Aug 07 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Aug 03 2017 | HZNP | Horizon Pharma plc | Shannon James Samuel | Director | Option Exercise | A | 0.00 | 24,610 | 0 | 24,610 | |
Aug 03 2017 | HZNP | Horizon Pharma plc | Shannon James Samuel | Director | Option Exercise | A | 12.19 | 52,232 | 636,708 | 52,232 | |
Aug 03 2017 | HZNP | Horizon Pharma plc | Witz Pascale | Director | Option Exercise | A | 0.00 | 24,610 | 0 | 24,610 | |
Aug 03 2017 | HZNP | Horizon Pharma plc | Witz Pascale | Director | Option Exercise | A | 12.19 | 52,232 | 636,708 | 52,232 | |
Jul 31 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Option Exercise | M | 0.00 | 5,675 | 0 | 5,675 | |
Jul 31 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Payment of Exercise | F | 11.98 | 2,662 | 31,891 | 31,500 | 34.2 K to 31.5 K (-7.79 %) |
Jul 31 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Buy | M | 0.00 | 5,675 | 0 | 34,162 | 28.5 K to 34.2 K (+19.92 %) |
Jun 26 2017 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 20,000 | 0 | 20,000 | |
Jun 26 2017 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 11.73 | 9,140 | 107,212 | 74,995 | 84.1 K to 75 K (-10.86 %) |
Jun 26 2017 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 20,000 | 0 | 84,135 | 64.1 K to 84.1 K (+31.18 %) |
May 22 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | M | 0.00 | 16,075 | 0 | 16,075 | |
May 22 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 10.50 | 7,347 | 77,144 | 62,597 | 69.9 K to 62.6 K (-10.50 %) |
May 22 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Buy | M | 0.00 | 16,075 | 0 | 69,944 | 53.9 K to 69.9 K (+29.84 %) |
May 10 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Buy | P | 9.48 | 10,000 | 94,800 | 25,448 | 15.4 K to 25.4 K (+64.73 %) |
May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Buy | M | 0.00 | 13,953 | 0 | 19,211 | 5.3 K to 19.2 K (+265.37 %) |
May 04 2017 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
May 04 2017 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
May 04 2017 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
May 04 2017 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Buy | M | 0.00 | 13,953 | 0 | 19,211 | 5.3 K to 19.2 K (+265.37 %) |
May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Payment of Exercise | F | 15.12 | 5,477 | 82,812 | 12,316 | 17.8 K to 12.3 K (-30.78 %) |
May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Buy | M | 0.00 | 13,953 | 0 | 17,793 | 3.8 K to 17.8 K (+363.36 %) |
May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Payment of Exercise | F | 15.12 | 3,763 | 56,897 | 14,030 | 17.8 K to 14 K (-21.15 %) |
May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Buy | M | 0.00 | 13,953 | 0 | 17,793 | 3.8 K to 17.8 K (+363.36 %) |
May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Payment of Exercise | F | 15.12 | 3,763 | 56,897 | 10,190 | 14 K to 10.2 K (-26.97 %) |
May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Buy | M | 0.00 | 13,953 | 0 | 13,953 | 0 to 14 K |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Payment of Exercise | F | 15.12 | 3,763 | 56,897 | 15,448 | 19.2 K to 15.4 K (-19.59 %) |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Buy | M | 0.00 | 13,953 | 0 | 19,211 | 5.3 K to 19.2 K (+265.37 %) |
May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Payment of Exercise | F | 15.12 | 4,219 | 63,791 | 24,388 | 28.6 K to 24.4 K (-14.75 %) |
May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Buy | M | 0.00 | 13,953 | 0 | 28,607 | 14.7 K to 28.6 K (+95.22 %) |
Apr 04 2017 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | EVP, Primary Care B ... | Option Exercise | M | 0.00 | 7,000 | 0 | 14,000 | |
Apr 04 2017 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | EVP, Primary Care B ... | Payment of Exercise | F | 14.78 | 2,937 | 43,409 | 24,726 | 27.7 K to 24.7 K (-10.62 %) |
Apr 04 2017 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | EVP, Primary Care B ... | Buy | M | 0.00 | 7,000 | 0 | 27,663 | 20.7 K to 27.7 K (+33.88 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 125,000 | 0 | 250,000 | |
Mar 24 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 14.56 | 57,125 | 831,740 | 446,721 | 503.8 K to 446.7 K (-11.34 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 125,000 | 0 | 503,846 | 378.8 K to 503.8 K (+32.99 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 19,250 | 0 | 38,500 | |
Mar 24 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 14.56 | 8,798 | 128,099 | 192,350 | 201.1 K to 192.4 K (-4.37 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 19,250 | 0 | 201,148 | 181.9 K to 201.1 K (+10.58 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | M | 0.00 | 19,250 | 0 | 38,500 | |
Mar 24 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 14.56 | 8,798 | 128,099 | 53,869 | 62.7 K to 53.9 K (-14.04 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Buy | M | 0.00 | 19,250 | 0 | 62,667 | 43.4 K to 62.7 K (+44.34 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 9,500 | 0 | 19,000 | |
Mar 24 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 14.56 | 4,342 | 63,220 | 29,499 | 33.8 K to 29.5 K (-12.83 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 9,500 | 0 | 33,841 | 24.3 K to 33.8 K (+39.03 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Option Exercise | M | 0.00 | 9,500 | 0 | 19,000 | |
Mar 24 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Payment of Exercise | F | 14.56 | 2,955 | 43,025 | 27,059 | 30 K to 27.1 K (-9.85 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Buy | M | 0.00 | 9,500 | 0 | 30,014 | 20.5 K to 30 K (+46.31 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 31,000 | 0 | 62,000 | |
Mar 24 2017 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 14.56 | 14,167 | 206,272 | 62,707 | 76.9 K to 62.7 K (-18.43 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 31,000 | 0 | 76,874 | 45.9 K to 76.9 K (+67.58 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 62,000 | |
Mar 24 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 14.56 | 14,167 | 206,272 | 34,190 | 48.4 K to 34.2 K (-29.30 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 48,357 | 17.4 K to 48.4 K (+178.60 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 9,500 | 0 | 19,000 | |
Mar 24 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 14.56 | 2,955 | 43,025 | 52,383 | 55.3 K to 52.4 K (-5.34 %) |
Mar 24 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 9,500 | 0 | 55,338 | 45.8 K to 55.3 K (+20.73 %) |
Mar 07 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,025 | 0 | 31,025 | |
Mar 07 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 16.11 | 14,268 | 229,857 | 17,357 | 31.6 K to 17.4 K (-45.12 %) |
Mar 07 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,025 | 0 | 31,625 | 600 to 31.6 K (+5,170.83 %) |
Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | X | 4.31 | 6,913 | 29,781 | 0 | |
Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Sell | S | 16.00 | 30,000 | 480,000 | 95,408 | 125.4 K to 95.4 K (-23.92 %) |
Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Sell | S | 16.48 | 1,808 | 29,796 | 125,408 | 127.2 K to 125.4 K (-1.42 %) |
Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | X | 4.31 | 6,913 | 29,781 | 127,216 | 120.3 K to 127.2 K (+5.75 %) |
Jan 11 2017 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | M | 2.40 | 1,815 | 4,356 | 0 | |
Jan 11 2017 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | M | 7.48 | 7,860 | 58,793 | 0 | |
Jan 11 2017 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Buy | M | 2.40 | 1,815 | 4,356 | 41,129 | 39.3 K to 41.1 K (+4.62 %) |
Jan 11 2017 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Buy | M | 7.48 | 7,860 | 58,793 | 39,314 | 31.5 K to 39.3 K (+24.99 %) |
Jan 04 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 49,500 | 0 | 49,500 | |
Jan 04 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 32,175 | 0 | 0 | |
Jan 04 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 16.18 | 37,703 | 610,035 | 378,846 | 416.5 K to 378.8 K (-9.05 %) |
Jan 04 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 81,675 | 0 | 416,549 | 334.9 K to 416.5 K (+24.39 %) |
Jan 04 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 15,500 | 0 | 15,500 | |
Jan 04 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 11,250 | 0 | 0 | |
Jan 04 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 16.18 | 12,602 | 203,900 | 181,898 | 194.5 K to 181.9 K (-6.48 %) |
Jan 04 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 26,750 | 0 | 194,500 | 167.8 K to 194.5 K (+15.95 %) |
Jan 04 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 3,200 | 0 | 3,200 | |
Jan 04 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 8,000 | 0 | 0 | |
Jan 04 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 16.18 | 3,871 | 62,633 | 45,838 | 49.7 K to 45.8 K (-7.79 %) |
Jan 04 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 11,200 | 0 | 49,709 | 38.5 K to 49.7 K (+29.08 %) |
Dec 19 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Dec 19 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 2.40 | 8,500 | 20,400 | 5,313 | |
Dec 19 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 2.40 | 8,500 | 20,400 | 167,750 | 159.3 K to 167.8 K (+5.34 %) |
Dec 05 2016 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 8,450 | 0 | 16,900 | |
Dec 05 2016 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 19.43 | 2,628 | 51,062 | 24,341 | 27 K to 24.3 K (-9.74 %) |
Dec 05 2016 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 8,450 | 0 | 26,969 | 18.5 K to 27 K (+45.63 %) |
Nov 08 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
Nov 08 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Payment of Exercise | F | 15.05 | 778 | 11,709 | 31,454 | 32.2 K to 31.5 K (-2.41 %) |
Nov 08 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Buy | M | 0.00 | 2,500 | 0 | 32,232 | 29.7 K to 32.2 K (+8.41 %) |
Sep 20 2016 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | M | 0.00 | 7,874 | 0 | 7,874 | |
Sep 20 2016 | HZNP | Horizon Pharma plc | Daniel William F | Director | Payment of Exercise | F | 19.12 | 2,381 | 45,525 | 14,654 | 17 K to 14.7 K (-13.98 %) |